UBS Maintains Neutral on FMC, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 57.1%

Neg 0% Neu 0% Pos 57.1%

UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and raises the price target from $14 to $17.

Comments

No comments yet. Be the first!